آخر تحديث: مايو 18, 2026
HPV or Human papillomavirus is one of the most common viral infections transmitted through sexual contact. It can lead to serious diseases including cervical cancer in females, penile cancer in males, and anal or oropharyngeal cancer in both sexes.

The US CDC reports 14 million new infections every year. Over 100 subtypes have been identified. Sexually active individuals are at risk of contracting at least one subtype in their lifetime even with a single partner and condom use. Most infections are asymptomatic and resolve within 2 years – 90% disappear without treatment. Only a small number persist and progress to cancer.
Not all subtypes cause cancer. Most cause only cosmetic conditions like genital warts. HPV types 16 and 18 are responsible for more than 70% of all cervical cancer cases.
There are 3 HPV vaccinations approved by US FDA and CDC:
- جارداسيل – Protects against 4 HPV strains causing 70% of cervical cancers and most genital warts. Suitable for both males and females.
- سيرفاريكس – Protects against 2 HPV strains causing 70% of cervical cancers. Suitable for females only.
- جارداسيل 9 – Protects against 9 HPV strains causing 90% of cervical cancers and most genital warts. Suitable for both males and females. This is currently the preferred vaccine.

Vaccination is most effective when given before first sexual activity. US CDC recommendation: 2 doses for those under 15 years old, and 3 doses for those 15 years and above. Vaccination also benefits older individuals by reducing genital wart recurrence. Studies confirm that protection from the vaccine introduced in 2006 remains durable over many years.
If you have questions or any assistance, please drop by my office.
If you are considering HPV vaccination for yourself or a family member, or want to discuss genital warts or HPV-related concerns, Dr. Soarawee Weerasopone offers specialist consultations at Bangkok Hospital Headquarters. احجز استشارة.
Frequently Asked Questions about HPV Vaccination
Human papillomavirus (HPV) is the most common sexually transmitted viral infection worldwide. While most infections resolve on their own within 2 years, persistent infection with high-risk strains – particularly types 16 and 18 – can lead to cervical cancer in women, penile cancer in men, and anal or oropharyngeal cancer in both sexes. Low-risk strains cause genital warts, which are not cancerous but are cosmetically distressing.
Yes. HPV vaccination is recommended for both males and females. In men, it reduces the risk of penile cancer, anal cancer, oropharyngeal cancer, and genital warts. Gardasil and Gardasil 9 are approved for use in males. Vaccinating men also reduces HPV transmission to female partners, contributing to population-level cancer prevention.
HPV vaccination is most effective when given before the first sexual exposure. The CDC recommends vaccination starting at age 11–12, ideally before adolescence. The schedule is 2 doses for those under 15, and 3 doses for those 15 and above. Vaccination can still provide benefit in older individuals who have not been previously vaccinated, particularly for genital wart prevention.
Gardasil protects against 4 HPV strains (types 6, 11, 16, 18) and is suitable for both sexes. Cervarix protects against 2 strains (types 16, 18) and is for females only. Gardasil 9 is the most comprehensive vaccine, covering 9 strains and protecting against 90% of cervical cancers and most genital warts. It is currently the preferred vaccine for both males and females.
Yes. While condoms significantly reduce HPV transmission risk, they do not provide complete protection because HPV can infect skin areas not covered by a condom. Studies show that even individuals with a single lifetime partner who consistently use condoms can contract HPV. This is why vaccination is strongly recommended in addition to safe sexual practices, as it provides the most reliable protection against high-risk strains.
إخلاء المسؤولية: هذا المحتوى مكتوب ومراجع من قبل الدكتورة سواروي ويراباسون، أخصائية أمراض المسالك البولية المعتمدة في مستشفى بانكوك الرئيسي. الغرض منه تعليمي فقط ولا يشكل نصيحة طبية. استشر دائمًا أخصائي رعاية صحية مؤهل قبل البدء في أي علاج طبي.
مكتوب طبياً ومراجع بواسطة: الدكتورة سوارافي ويراسوبون (الدكتورة بوم) - أخصائية المسالك البولية المعتمدة، مستشفى بانكوك الرئيسي. زمالة دولية: كلية بايلور للطب (الولايات المتحدة الأمريكية) · جامعة جوندندو (اليابان) · مستشفى تشانغ غونغ التذكاري (تايوان).

الدكتور سواراوي ويرسوبون (د. بوم) هو أخصائي مسالك بولية معتمد من البورد في مستشفى بانكوك الرئيسي، متخصص في صحة الرجل، والجراحة الروبوتية (نظام دافنشي)، وعلاج حصوات الكلى. أكمل زمالات دولية في كلية بايلور للطب (الولايات المتحدة الأمريكية)، ومستشفى جامعة جـونتـندو (اليابان)، ومستشفى تشانغ جـونج التذكاري (تايوان). كل المحتوى الطبي الموجود على هذا الموقع مكتوب ومراجع من قبل الدكتور سواراوي بناءً على خبرته السريرية وتدريبه الدولي.


رد واحد